Pancreatic Cancer Research

ResearcherEndeavor HealthActive in the last 2 years

Mark S. Talamonti

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7561-6916; OpenAlex author ID A5054101341. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 6

  1. Pretreatment CA19-9 Predicts Survival in Pancreatic Cancer With Optimal Response to Neoadjuvant Therapy. Co-author DOI 10.1002/jso.70179↗
  2. Multimodal Therapy May be Key to Improving Survival for Octogenarians Undergoing Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: An American Mult… Co-author DOI 10.1245/s10434-025-16916-7↗
  3. Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlations. Co-author DOI 10.1038/s41598-024-65562-8↗
  4. Management Controversies and Treatment Strategies for Borderline Resectable Pancreatic Cancer. Co-author DOI 10.1007/978-3-319-34244-3_4↗
  5. Screening Strategies for Pancreatic Cancer in High-Risk Patients Co-author DOI 10.1001/jamasurg.2015.0391↗
  6. Phase II trial of full-dose gemcitabine and bevacizumab in combination with attenuated three-dimensional conformal radiotherapy in patients with localized panc… Last author DOI 10.1016/j.ijrobp.2010.02.030↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Melissa Ellen Hogg · 2 shared papers, 2025–2026 · strength 0.42
  2. Sarah B. Hays · 2 shared papers, 2025–2026 · strength 0.42
  3. Patricio Marcelo Polanco · 2 shared papers, 2025–2026 · strength 0.42
  4. Asmita Chopra · 2 shared papers, 2025–2026 · strength 0.42
  5. Amer H. Zureikat · 2 shared papers, 2025–2026 · strength 0.42
  6. Emile Farah · 2 shared papers, 2025–2026 · strength 0.42
  7. Herbert J. Zeh · 2 shared papers, 2025–2026 · strength 0.42
  8. Brian A. Boone · 2 shared papers, 2025–2026 · strength 0.42
  9. Alessandro Paniccia · 2 shared papers, 2025–2026 · strength 0.42
  10. Anthony Gebran · 1 shared paper, 2026 · strength 0.23
  11. Sebastiaan Ceuppens · 1 shared paper, 2026 · strength 0.23
  12. Talent Theparee · 1 shared paper, 2024 · strength 0.20
  13. Karen Lynn Kaul · 1 shared paper, 2024 · strength 0.20
  14. Caroline J. Rieser · 1 shared paper, 2025 · strength 0.19
  15. Amudhan Kannan · 1 shared paper, 2025 · strength 0.19
  16. Imad Radi · 1 shared paper, 2025 · strength 0.19
  17. David J. Bentrem · 1 shared paper, 2011 · strength 0.03
  18. William C. Small · 1 shared paper, 2011 · strength 0.03
  19. Al B. Benson · 1 shared paper, 2011 · strength 0.03
  20. Mary F. Mulcahy · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.